Rainbow Childrens Medicare Ltd

Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO. This rating was last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Rainbow Childrens Medicare Ltd’s shares declined sharply to a new 52-week low of Rs.1008.75 on 2 March 2026, marking a significant price level for the hospital sector stock amid a three-day losing streak and broader market volatility.

Rainbow Childrens Medicare Ltd, a key player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest day gain of 1.70%, the company’s technical indicators reveal a complex picture, with several signals pointing towards caution for investors amid mixed momentum and valuation challenges.

Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO. This rating was last updated on 22 September 2025, reflecting a shift from the previous Hold status. However, the analysis and financial metrics discussed below are based on the stock's current position as of 23 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Rainbow Childrens Medicare Ltd has experienced a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a 3.00% rise in the latest session, the stock faces mixed signals from key momentum and trend-following tools, underscoring the challenges investors face in navigating its near-term trajectory.

Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO. This rating was last updated on 22 September 2025, reflecting a shift from a previous Hold stance. However, the analysis and financial metrics discussed here represent the stock’s current position as of 11 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Rainbow Childrens Medicare Ltd has touched a new 52-week low of Rs.1090 today, marking a significant decline amid broader market fluctuations and sectoral underperformance. The stock's recent trajectory reflects a series of challenges impacting its valuation and market sentiment.

Rainbow Childrens Medicare Ltd’s stock declined sharply to a fresh 52-week low of Rs.1110.5 on 3 February 2026, marking a significant setback after a brief two-day rally. The stock underperformed its sector by 4.66% and closed the day down 3.02%, reflecting growing concerns among market participants.

Rainbow Childrens Medicare Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a modest day gain of 0.29%, the hospital sector stock’s broader technical landscape suggests caution for investors as momentum indicators and moving averages point to weakening price strength.

Rainbow Childrens Medicare Ltd, a key player in the hospital sector, has touched a new 52-week low of Rs 1122.05 today, marking a significant decline in its stock price amid broader market fluctuations and sectoral pressures.

Rainbow Childrens Medicare Ltd, a key player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bearish signals across multiple timeframes. Despite a modest day gain of 1.04%, the stock’s broader technical indicators suggest caution for investors as the company’s mojo grade was downgraded from Hold to Sell on 22 September 2025.

Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Rainbow Childrens Medicare Ltd has reached a new 52-week low of Rs.1136.9, marking a significant decline in its stock price amid broader market pressures and company-specific performance factors.

Rainbow Childrens Medicare Ltd has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. Despite achieving record net sales, the company’s overall financial trend has stagnated, prompting a downgrade in its Mojo Grade from Hold to Sell as of 22 September 2025.